Nadav Kidron  photo: Tamar Matsafi Insulin capsule trial results lift Oramed 80%

Oramed's insulin capsule is designed for the early stage of type 2 diabetes treatment.

Bar Refaeli, Kim Kardashian in Carolina Lemke campaign / Photo: PR Castro, Carolina Lemke parting from Kim Kardashian

Castro is disappointed with Carolina Lemke's results in the US, and is terminating its agreement with Kardashian.

Kamada Kamada to market 6 new products in Israel

The company says that the agreement with Alvotech will generate $20-30 million peak annual revenue.

Pnina Rosenblum / Photo: Tamar Matsafi, Globes Pnina Rosenblum eyes Internet Gold for cannabis cosmetics

Rosenblum is offering NIS 4 million for the stock exchange shell.

Be pharmacy in Eilat / Photo: Shir Golani Shufersal to close Be pharmacy branches

The Be chain, acquired two years ago from Hamashbir Lazarchan as New Pharm, will close 6% of its branches in 2020.

Ari Bronshtein Elron CEO resigns amid dispute with Elsztain

Ari Bronshtein is the latest in a series of IDB Development-Discount Investment group executives who have decided to leave.

cancer Alpha Tau's new cancer radiology method proves effective

The new method is designed to provide more powerful and focused treatment.

Michelle Heymann and Diane Abensur / Photo: private photo Nanosynex aims to solve antibiotic resistance

The company has developed a way of precisely adapting antibiotics to infections.

XACT Robotics Medical device co XACT Robotics raises $36m

XACT Robotics has developed a device, with FDA approval and CE Mark, for guiding instruments to precise locations in the body.

Be pharmacy Be pharmacy chain weighs on Shufersal results

Overall, group revenue and margins rose in the third quarter, but high finance expenses cut profit

Teva Photo: Sivan Faraj Teva in US federal probe of opioids affair

The Wall Street Journal reports that Teva and other companies are being investigated on the basis of laws against drug dealers.

Teva Photo: Sivan Faraj Teva teams with Weizmann Institute, Tel Aviv U

Teva aims to strengthen its ties with institutions of higher education in Israel and bring brains back to Israel.

Kare Schultz Photo: Shlomi Yosef Teva jumps on reported US price-fixing settlement talks

According to Bloomberg, in talks with the US Justice Department, Teva and other companies will admit some of the allegations and pay fines.

Tikun Olam cannabis greenhouse Tikun Olam valuation slashed in Cannbit deal

Cannbit will pay $23 million immediately plus 4.99% of its shares for Tikun Olam's Israel activity, plus $18 million conditional on revenue.

Sheba ARC Innovation Center  / Photo: Cadya Levi Sheba Medical Center launches digital innovation center

The ARC center fosters local and international collaboration for digital healthcare projects, with on the spot input from doctors and nurses.

Jeremy Levin "From Teva's ashes new Israeli biotech can grow"

Former Teva CEO Jeremy Levin talks to "Globes" about Israel's biotech potential, the opioid disaster and why he shuns investing in medical cannabis.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018